Sonic joins trend of taking orders by smartphone

OKLAHOMA CITY �� Sonic Drive-In is joining fast-food industry trends allowing customers to get what they want even faster thanks to smartphones.

The Oklahoman reports the Oklahoma City-based chain has been testing an app that allows consumers to order food and drinks and pick a location and pickup time before they arrive. The app has been tested Lafayette, Louisiana, and will be available in Oklahoma City by the end of May.

Sonic hopes to have the service available nationally by the end of 2018.

McDonald's rolled out a similar app aimed at saving precious seconds and cutting down on pileups in drive-thru lines.

Chief Brand Officer Jose Duenas said the app will make Sonic more personalized and competitive. Duenas said Sonic studied Starbucks, Panera and Domino's because they use similar technology.

Information from: The Oklahoman

More: Starbucks anti-bias training: Here's what to expect as the coffee chain closes 8,000 stores

More: What does average American get from Social Security? Depends on the benefit

More: 'Passport Plum?' Delta rolls out new uniforms for 64,000 frontline workers

Top 10 Bank Stocks To Invest In Right Now

tags:CORE,ESRX,FTAI,PRU,MMM,APDN,HDSN,BCRX,VLRS,THS,

Consumer and corporate borrowing has rebounded this year, and the economy looks to book its third consecutive quarter over 3% growth for the final three months of the year. That would have shares of financial institutions booming were it not for two factors working against the industry.

Shares of banks have underperformed this year on a narrow net interest margin, the difference between long-term and short-term rates, and continued regulatory costs from post-crisis legislation. The SPDR S&P Bank ETF (NYSE: KBE) has returned just 3.3% this year versus a 15% increase in the broader S&P 500 index.

Despite increases in the short-term benchmark rate by the Federal Reserve and more on the way, higher rates on the short end of the yield curve haven't translated to higher long-term rates. Subdued inflation and fears over long-term economic growth have kept the rate on the 10-year Treasury well under 3% all year.

That means the net interest spread, the difference between the rate paid by banks on deposits and what they collect on longer-term loans, has held back profits.

Top 10 Bank Stocks To Invest In Right Now: Core-Mark Holding Company Inc.(CORE)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Core-Mark (CORE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Bank Stocks To Invest In Right Now: Express Scripts Holding Company(ESRX)

Advisors' Opinion:

• [By ]

  The space that could come under the most pressure are the pharmacy benefit management players, an industry that thrives on the rebate system. Stocks to watch include: CVS Health (CVS) (owns PBM Caremark) and Express Scripts (ESRX) (and by extension Cigna (CI) , which is trying to acquire Express Scripts).

• [By ]

  Larry Robbins and his Glenview Capital Management LLC said he is supportive of health insurance titan Cigna Corp.'s (CI) acquisition of Express Scripts Holdings Co. (ESRX) , the country's largest benefits management group, in a deal announced in March worth $67 billion.

• [By Cory Renauer]

  Regeneron's cholesterol-lowering medication Praluent was another drug with multibillion-dollar potential that's been a huge disappointment in the commercial setting. Trying to launch a treatment with a $14,000-per-year price tag didn't work, but a more affordable solution is getting attention from the right people. Express Scripts (NASDAQ:ESRX), a pharmacy benefits manager with a national formulary that covers around 25 million Americans, recently agreed to a straightforward reimbursement path in return for drastically lowered pricing. Express Scripts also removed Praluent's market rival Repatha from its formulary.

• [By WWW.GURUFOCUS.COM]

  For the details of Jeff Ubben's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

  These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) - 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) - 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) - 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) - 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) - 17,959,620 shares,
• [By Logan Wallace]

  Brinker Capital Inc. increased its position in Express Scripts (NASDAQ:ESRX) by 11.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 84,842 shares of the company’s stock after purchasing an additional 8,605 shares during the quarter. Brinker Capital Inc.’s holdings in Express Scripts were worth $5,861,000 at the end of the most recent quarter.

• [By ]
  It may be unhealthy to trade drug stocks Friday. The word on Wall Street is to not expect too much from President Trump's speech on drug prices. That means expect the unexpected, and prepare for a volatility spike in key healthcare names such as Express Scripts (ESRX) , CVS Health (CVS) , Endo International (ENDP) , Mallinckrodt (MNK) , McKesson (MCK) and Cardinal Health (CAH) .

  Reports TheStreet's Bill Meagher: "Evercore ISI may be an outlier as its analysts anticipate that recent speeches by officials from the Food and Drug Administration, Health and Human Services and Centers for Medicare & Medicaid Services may have telegraphed the Trump administration's willingness to move beyond loud talk and tweets into policy discussions. In those tweets and in talks with his cabinet, Trump has been critical of the pharmaceutical sector and its pricing of prescription drugs, famously saying on at least two occasions that companies are "getting away with murder."

Top 10 Bank Stocks To Invest In Right Now: Fortress Transportation and Infrastructure Investors LLC(FTAI)

Advisors' Opinion:

• [By Logan Wallace]

  These are some of the media stories that may have effected Accern Sentiment’s scoring:

  Fortress Transportation and Infrastructure Investors (FTAI) Lifted to B- at TheStreet (americanbankingnews.com) BidaskClub Upgrades Fortress Transportation and Infrastructure Investors (FTAI) to “Buy” (americanbankingnews.com) Active Mover �� Fortress Transportation and Infrastructure Investors LLC (NYSE: FTAI) (alphabetastock.com) Services Stock Buzz: Fortress Transportation and Infrastructure Investors LLC (FTAI) (stocksgeeks.com) Contrasting H&E Equipment Services (HEES) & Fortress Transportation and Infrastructure Investors (FTAI) (americanbankingnews.com)

  Shares of FTAI opened at $16.25 on Friday. The stock has a market cap of $1,365.03, a PE ratio of 135.42 and a beta of 1.56. Fortress Transportation and Infrastructure Investors has a 12-month low of $14.25 and a 12-month high of $20.13.

Top 10 Bank Stocks To Invest In Right Now: Prudential Financial Inc.(PRU)

Advisors' Opinion:

• [By Zacks]

  Well, given the growing demand for securitized mortgage deals, Barclays plans to package and sell these Irish loans over the next two months. The group of investors that has shown interest in buying residential mortgage backed securities includes M&G Investments, the investment management division of British insurer Prudential Plc (NYSE: PRU) and Pacific Investment Management Co. ("PIMCO").

• [By Jason Hall, Chuck Saletta, and Reuben Gregg Brewer]

  But that doesn't mean you need to make risky bets to capture solid returns, either, and buying solid companies at reasonable prices can help create a margin of safety and improve your returns, while also decreasing your risk of permanent losses. Three stocks that meet these criteria are small healthcare real-estate specialist�Caretrust REIT Inc�(NASDAQ:CTRE), financial services giant�Prudential Financial Inc�(NYSE:PRU), and energy behemoth�ExxonMobil Corporation�(NYSE:XOM).�

• [By Max Byerly]

  Flippin Bruce & Porter Inc. grew its holdings in shares of Prudential Financial (NYSE:PRU) by 2.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 61,363 shares of the financial services provider’s stock after acquiring an additional 1,391 shares during the period. Flippin Bruce & Porter Inc.’s holdings in Prudential Financial were worth $6,354,000 as of its most recent SEC filing.

Top 10 Bank Stocks To Invest In Right Now: 3M Company(MMM)

Advisors' Opinion:

• [By Lee Samaha]

  3M Company's (NYSE:MMM) rich valuation meant that any kind of growth mishap in 2018 was going to hurt the stock, and that's just what happened after the company's recent first-quarter earnings report. That said, after Boeing, 3M Company is the largest industrial company by market cap, and it's often a good idea to buy into a great company after it stumbles momentarily. So is it now time to buy into the Dividend Aristocrat? Here are four reasons to avoid the stock and two reasons to buy it.

• [By Paul Ausick]

  The second-worst Dow stock so far this year is General Electric Co. (NYSE: GE), which is down 16.3%. That is followed by Walmart Inc. (NYSE: WMT), down 15.6%, 3M Co (NYSE: MMM), down 12.8%, and Johnson & Johnson (NYSE: JNJ), down 8.9%. With the exception of Walmart, which is spending some $15 billion to acquire a majority stake in India’s Flipkart, the five worst performers all cut their losses last week, with GE adding about 3.6% to its share price.

• [By Lisa Levin] Companies Reporting Before The Bell United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion. The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion. Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion. Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion. Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion. The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion. Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion. 3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion. JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion. Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion. Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion. Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion. Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion. The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion. Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion. PACCAR Inc (NASDAQ: PCAR) is projected to
• [By Paul Ausick]

  3M Company (NYSE: MMM) traded down 2.91% at $216.66 in a 52-week range of $188.62 to $259.77. Volume of about 3.3 million shares was around 30% above the daily average. The company had no specific news Friday.

Top 10 Bank Stocks To Invest In Right Now: Applied DNA Sciences Inc(APDN)

Advisors' Opinion:

• [By Max Byerly]

  These are some of the media headlines that may have effected Accern Sentiment’s rankings:

  Get Applied DNA Sciences alerts: Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

  A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

• [By Shane Hupp]

  Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Top 10 Bank Stocks To Invest In Right Now: Hudson Technologies, Inc.(HDSN)

Advisors' Opinion:

• [By Shane Hupp]

  Hudson Technologies (NASDAQ:HDSN) released its quarterly earnings results on Wednesday. The industrial products company reported ($0.02) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.01 by ($0.03), Bloomberg Earnings reports. Hudson Technologies had a return on equity of 6.44% and a net margin of 1.64%. The business had revenue of $42.43 million during the quarter, compared to the consensus estimate of $45.88 million.

• [By Lisa Levin]

  Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 29 percent to $2.9199 after the company reported downbeat Q1 earnings.

  Commodities

• [By Ethan Ryder]

  Hudson Technologies, Inc. (NASDAQ:HDSN) traded up 20.3% during trading on Thursday following insider buying activity. The company traded as high as $2.73 and last traded at $2.61. 2,803,817 shares changed hands during mid-day trading, an increase of 473% from the average session volume of 488,999 shares. The stock had previously closed at $2.17.

Top 10 Bank Stocks To Invest In Right Now: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Bank Stocks To Invest In Right Now: Controladora Vuela Compania de Aviacion, S.A.B. de C.V.(VLRS)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements. Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter. Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn. Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron. Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line. Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday. Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63. Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results. Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26. Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent
• [By Adam Levine-Weinberg]

  In late 2016 and early 2017, profitability deteriorated rapidly at Mexican budget airline Volaris (NYSE:VLRS)�due to market disruptions caused by the U.S. presidential election. Fears about a crackdown on trade or immigration under President Trump led to a sharp drop in the Mexican peso and a downturn in travel demand. However, Volaris seemed to be on the mend by this time last year, and its stock price rebounded to more than $15 last July.

• [By Travis Hoium]

  Shares of Mexican airline Controladora Vuela Co Avcn SA CV (NYSE:VLRS) plunged as much as 20.3% in trading Monday after announcing earnings that led to fears of growing competition. At 12:25 p.m. EDT shares were still down 16.6% on the day.�

Top 10 Bank Stocks To Invest In Right Now: Treehouse Foods, Inc.(THS)

Advisors' Opinion:

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90. Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months. Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00. Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday. STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results. Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday. Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share. YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings. ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15. MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings. Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings. TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results. Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings. TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results. Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings. Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results. Logitech International S.A. (NASDAQ: LOGI)
• [By Joseph Griffin]

  Shares of TreeHouse Foods (NYSE:THS) have been assigned an average rating of “Hold” from the twenty-one research firms that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, thirteen have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $49.75.

• [By Stephan Byrd]

  State of New Jersey Common Pension Fund D reduced its holdings in TreeHouse Foods (NYSE:THS) by 40.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 240,000 shares of the company’s stock after selling 160,000 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in TreeHouse Foods were worth $9,185,000 as of its most recent SEC filing.

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday. Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each. Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55. Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months. Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75. STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results. Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday. China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday. YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings. MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings. Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share. Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701. Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings. The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings. Ca
• [By Ethan Ryder]

  Peel Hunt reaffirmed their buy rating on shares of Tharisa (LON:THS) in a research report released on Tuesday morning. They currently have a GBX 230 ($3.12) price target on the stock.

Hot Heal Care Stocks To Own Right Now

tags:KOOL,DNBF,HEES,NRE,MAN,

(Published Feb. 26 by Bob Ciura)

Finding stocks that have paid 100 years of dividends is no easy task. Couple this with a 3%-plus starting yield, and the task becomes that much harder.

CenterPoint Energy (NYSE:CNP) is one of a select few blue chip stocks that offers both. In fact, it goes even further – it has a 4% dividend yield.

It makes the list thanks to its steady business model. CenterPoint is an electric and gas utility, which is one of the most stable business models an investor can find.

CenterPoint recently increased its dividend by 4%, to $1.07 per share annualized. This was its 12th year in a row of consecutive dividend growth.

CenterPoint is a Dividend Achiever, a group of 272 stocks with 10-plus years of consecutive dividend increases.

You can see the full Dividend Achievers List here.

Business model

CenterPoint isn’t a run-of-the-mill utility. Most utility stocks are pure-play electric utilities.

Hot Heal Care Stocks To Own Right Now: THERMOGENESIS Corp.(KOOL)

Advisors' Opinion:

• [By Lisa Levin]

  Shares of Cesca Therapeutics Inc. (NASDAQ: KOOL) were down 21 percent to 0.88 after reporting Q1 results.

  Netshoes (Cayman) Limited (NASDAQ: NETS) was down, falling around 36 percent to $3.27 as the company posted downbeat Q1 results.

• [By Lisa Levin]

   

  Losers Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results. Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results. SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss. Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday. Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million. Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday. ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today. ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79. Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss. Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss. iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results. Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97. Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15. AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings. Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49. Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday. Myomo, Inc. (NYSE: MYO) slipp
• [By Paul Ausick]

  Cesca Therapeutics Inc. (NASDAQ: KOOL) traded down nearly 34% Wednesday to post a new 52-week low of $0.52 after closing Tuesday at $0.80. The stock’s 52-week high is $6.44. Volume was about 40 times the daily average of around 142,000 shares. The company priced a secondary offering of 9.17 million units at $0.60 per unit of one common share and one common warrant to purchase an additional common share.

Hot Heal Care Stocks To Own Right Now: DNB Financial Corp(DNBF)

Advisors' Opinion:

• [By Stephan Byrd]

  Media headlines about DNB Financial (NASDAQ:DNBF) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DNB Financial earned a coverage optimism score of 0.01 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 47.919917781005 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Hot Heal Care Stocks To Own Right Now: H&E Equipment Services Inc.(HEES)

Advisors' Opinion:

• [By Peter Graham]

  A long term performance chart shows shares of United Rentals�giving a similar performance but also�pulling away from�small cap peer H&E Equipment Services, Inc (NASDAQ: HEES):

Hot Heal Care Stocks To Own Right Now: NorthStar Realty Europe Corp.(NRE)

Advisors' Opinion:

• [By Shane Hupp]

  Teachers Insurance & Annuity Association of America increased its holdings in NorthStar Realty Europe (NYSE:NRE) by 15.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,499 shares of the financial services provider’s stock after purchasing an additional 9,699 shares during the period. Teachers Insurance & Annuity Association of America owned approximately 0.13% of NorthStar Realty Europe worth $931,000 as of its most recent SEC filing.

• [By Stephan Byrd]

  NorthStar Realty Europe (NYSE:NRE) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $17.17.

Hot Heal Care Stocks To Own Right Now: ManpowerGroup(MAN)

Advisors' Opinion:

• [By Shane Hupp]

  TRADEMARK VIOLATION WARNING: “ManpowerGroup (MAN) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3373626/manpowergroup-man-posts-quarterly-earnings-results-beats-estimates-by-0-09-eps.html.

• [By ]

  2. Staffing firms could do well as employees look to other options if their employers won't raise rates along with the trend. Firms like Robert Half International (NYSE: RHI) and ManpowerGroup (NYSE: MAN) would also benefit from higher wages through the fees the companies collect when they place an employee contract.

• [By Dan Caplinger]

  Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here's why they did so poorly.

• [By Shane Hupp]

  Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lowered its stake in shares of ManpowerGroup (NYSE:MAN) by 12.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,463 shares of the business services provider’s stock after selling 1,109 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in ManpowerGroup were worth $859,000 at the end of the most recent reporting period.

Top 10 Biotech Stocks To Buy For 2018

tags:AMGN,ALNY,BIIB,ARQL,

Exelixis (NASDAQ:EXEL) – Investment analysts at William Blair raised their FY2018 earnings per share (EPS) estimates for shares of Exelixis in a research report issued to clients and investors on Thursday, May 3rd. William Blair analyst A. Hsieh now anticipates that the biotechnology company will post earnings per share of $0.90 for the year, up from their previous estimate of $0.66. William Blair currently has a “Buy” rating on the stock. William Blair also issued estimates for Exelixis’ Q1 2019 earnings at $0.23 EPS, Q2 2019 earnings at $0.25 EPS, Q3 2019 earnings at $0.27 EPS and Q4 2019 earnings at $0.29 EPS.

Get Exelixis alerts:

A number of other research analysts have also issued reports on the company. Stifel Nicolaus reduced their price target on Exelixis from $30.00 to $29.00 and set a “hold” rating for the company in a research report on Thursday, May 3rd. Zacks Investment Research upgraded Exelixis from a “sell” rating to a “hold” rating in a report on Monday, April 30th. BidaskClub lowered Exelixis from a “sell” rating to a “strong sell” rating in a report on Wednesday, April 4th. Cann restated a “buy” rating and issued a $40.00 price objective on shares of Exelixis in a report on Tuesday, March 20th. Finally, TheStreet lowered Exelixis from a “b” rating to a “c+” rating in a report on Thursday, March 15th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $34.00.

Top 10 Biotech Stocks To Buy For 2018: Amgen Inc.(AMGN)

Advisors' Opinion:

• [By Todd Campbell]

  When a brand new class of cholesterol-lowering drugs called PCSK9 inhibitors won Food and Drug Administration (FDA) approval in 2015, it was heralded as the biggest advance in battling heart disease since the invention of statins. The launch of PCSK9 inhibitors was accompanied by billion-dollar-plus predictions for sales. However, revenue has fallen far shy of blockbuster status, leaving drugmakers Amgen Inc. (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), and Sanofi SA (NYSE:SNY) in the lurch.

• [By Cory Renauer]

  Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER's assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by the�Express Scripts (NASDAQ:ESRX) national formulary. The�pharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen's (NASDAQ:AMGN) Repatha.

• [By Logan Wallace]

  Intact Investment Management Inc. grew its holdings in Amgen (NASDAQ:AMGN) by 2,737.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,400 shares of the medical research company’s stock after purchasing an additional 43,800 shares during the period. Intact Investment Management Inc.’s holdings in Amgen were worth $7,739,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Cory Renauer]

  There's a lot for investors to like about�Amgen Inc. (NASDAQ:AMGN) and�Biogen Inc. (NASDAQ:BIIB). Both of these biotech stocks have produced tremendous returns over the past couple of decades, and the businesses they represent still generate enormous profits.�

• [By Trey Thoelcke]

  Amgen Inc. (NASDAQ: AMGN) shares saw a nice bump after the U.S. Food and Drug Administration (FDA) on Thursday approved Aimovig (erenumab), Amgen’s preventive treatment of migraine in adults. It is the first FDA-approved preventive migraine treatment in a new class of drugs, which work by blocking the activity of calcitonin gene-related peptide, which is believed to play a critical role in migraine attacks.

• [By Chris Lange]

  Amgen Inc. (NASDAQ: AMGN) shares made a slight gain on Tuesday after it was announced that the U.S. Food and Drug Administration (FDA) approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture. Specifically, the agency approved Prolia (denosumab), driven by positive late-stage results.

Top 10 Biotech Stocks To Buy For 2018: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:

• [By Brian Orelli]

  The delay in an FDA decision for Tegsedi puts it behind competitor Alnylam Pharmaceuticals (NASDAQ:ALNY), which expects to hear from the FDA by Aug. 11 for its hATTR drug patisiran. But Sarah Boyce, the president at Akcea Therapeutics, doesn't think a few months will really matter: "We don't really feel that's going to have any impact and the drugs will be close enough together from a launch perspective. So not really [going] to make any adjustments, and we're very well prepared to be ready to launch following approval."

• [By Keith Speights]

  I wrote three months ago that I viewed Alnylam Pharmaceuticals (NASDAQ:ALNY) stock as a pretty good pick -- but with a couple of qualifications. First, I didn't think that the biotech would generate returns in 2018 nearly as great as it did last year. Second, I thought that there were even better stocks to buy than Alnylam.

• [By Max Byerly]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.

• [By Brian Orelli]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) released first-quarter results last week, but all eyes were looking forward as the company waits for a potential approval of its hereditary TTR amyloidosis (ATTR) drug, patisiran.

Top 10 Biotech Stocks To Buy For 2018: Biogen Idec Inc(BIIB)

Advisors' Opinion:

• [By Chris Lange]

  Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen Inc. (NASDAQ: BIIB). Through this partnership, these companies are planning to tackle and develop novel antisense drug candidates for a broad range of neurological diseases.

• [By Brian Orelli]

  Drug-developer Biogen (NASDAQ:BIIB) reported a pretty strong earnings�increase in the first quarter. While revenue growth wasn't as solid, investors appear to be giving management a pass, thanks to its explanations on why slowing first-quarter sales aren't a sign of future trouble.

• [By Garrett Baldwin]
  Markets are keeping a close eye on the 10-year bond, which is hovering near 3% – an important psychological level that is likely to influence future price movements. On Monday, Fox Business Network's "Varney & Co." asked Money Morning Chief Investment Strategist Keith Fitz-Gerald if investors should be worried. Here's what Keith had to say about the 10-year Treasury yield… and how it will affect your stocks and bonds in the future. The price of Brent crude oil topped $75.00 and hit its highest level since November 2014. Oil traders were eyeing the ongoing efforts of OPEC and Russia to reduce excessive production around the globe, rising demand ahead of peak driving season, and the possibility that the Trump administration will slap Iran with a new round of sanctions. Three Stocks to Watch Today: KO, GOOGL, SLM Shares of The Coca-Cola Co.�(NYSE: KO) added 1.2% after the firm easily beat earnings and revenue expectations. The firm cited strong demand for its new flavors of Diet Coke and its Coke Zero Sugar. Demand was so strong for the quarter that the firm reported organic sales growth of 5%. The company reported earnings per share of $0.47, topping estimates by a penny. Revenue of $7.6 billion easily beat Wall Street estimates. Shares of Alphabet Inc. (Nasdaq: GOOGL) seesawed in pre-market hours. The online search giant topped Wall Street earnings and revenue expectations after the bell Monday. However, shares were off 0.5% after executives announced that its business costs were on the rise. The firm's real estate and computer purchases tripled in one year, to $7.3 billion. About one-third of that total came from its $2.4 billion purchase of the Chelsea Market building in New York City. Good news for SLM Corp.�(NYSE: SLM) investors, but bad news for indebted college students and graduates. The firm – also known as Sallie Mae – topped Wall Street earnings expectations on Monday. The firm said that it increased its loan o
• [By George Budwell]

  Biotech heavyweight Biogen (NASDAQ:BIIB) has now lost over 13% of its value so far this year. To be fair, this year hasn't been kind to biotechs in general, thanks to President Trump's aggressive trade policies with China.�But Biogen's value has been declining at a far faster rate than the industry as a whole due to stiffer competition in the all-important multiple sclerosis (MS) space.

Top 10 Biotech Stocks To Buy For 2018: ArQule Inc.(ARQL)

Advisors' Opinion:

• [By Logan Wallace]

  BidaskClub upgraded shares of ArQule (NASDAQ:ARQL) from a hold rating to a buy rating in a report released on Saturday.

  A number of other research firms have also issued reports on ARQL. Roth Capital upped their price target on ArQule from $5.00 to $6.00 and gave the company a buy rating in a research report on Tuesday, April 17th. Leerink Swann upgraded ArQule from a market perform rating to an outperform rating in a research report on Thursday, April 5th. Zacks Investment Research lowered ArQule from a buy rating to a hold rating in a research report on Wednesday, April 4th. ValuEngine upgraded ArQule from a hold rating to a buy rating in a research report on Wednesday, May 2nd. Finally, B. Riley set a $4.00 price target on ArQule and gave the company a buy rating in a research report on Monday, March 26th. Seven analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and an average target price of $4.69.

• [By Stephan Byrd]

  ArQule, Inc. (NASDAQ:ARQL) Director Ronald M. Lindsay acquired 23,900 shares of the company’s stock in a transaction on Thursday, May 10th. The stock was acquired at an average price of $2.67 per share, for a total transaction of $63,813.00. Following the purchase, the director now directly owns 43,900 shares of the company’s stock, valued at $117,213. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

• [By Lisa Levin] Gainers Foot Locker, Inc. (NYSE: FL) rose 15.3 percent to $53.50 in pre-market trading after the company reported better-than-expected results for its first quarter. Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 10.4 percent to $4.58 in pre-market trading. Evofem Biosciences reported closing of public offering of common stock and warrants. Resonant Inc. (NASDAQ: RESN) rose 7.3 percent to $4.88 in pre-market trading after declining 1.94 percent on Thursday. SolarEdge Technologies, Inc. (NASDAQ: SEDG) shares rose 5.7 percent to $59.65 in pre-market trading after falling 8.43 percent on Thursday. Yirendai Ltd. (NYSE: YRD) rose 5 percent to $30.00 in pre-market trading after reporting Q1 results. Deckers Outdoor Corp (NYSE: DECK) rose 4.9 percent to $108.75 in pre-market trading after reporteingd better-than-expected results for its fiscal fourth quarter. Blue Apron Holdings, Inc. (NYSE: APRN) rose 4.2 percent to $3.21 in pre-market trading after gaining 3.70 percent on Thursday. Recro Pharma, Inc. (NASDAQ: REPH) rose 4 percent to $5.85 in pre-market trading after dropping 54.67 percent on Thursday. ArQule, Inc. (NASDAQ: ARQL) rose 3.8 percent to $4.70 in pre-market trading after gaining 4.86 percent on Thursday. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares rose 2.9 percent to $2.85 in pre-market trading after climbing 7.78 percent on Thursday. Bilibili Inc. (NASDAQ: BILI) shares rose 2.5 percent to $14.20 in pre-market trading after surging 11.33 percent on Thursday.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Joseph Griffin]

  ArQule (NASDAQ:ARQL)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. They currently have a $6.00 price target on the biotechnology company’s stock, up from their prior price target of $5.00. Needham & Company LLC’s price target suggests a potential upside of 134.38% from the company’s previous close.

• [By Lisa Levin] Gainers Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares surged 20.6 percent to $6.39. WBB Securities upgraded Melinta Therapeutics from Hold to Speculative Buy. Shoe Carnival, Inc. (NASDAQ: SCVL) shares climbed 17.2 percent to $30.87 after the company reported upbeat quarterly earnings. Acorn International, Inc. (NYSE: ATV) shares rose 15.2 percent to $28.804 after the company declared a special one-time cash dividend of $14.97 per ADS. Foot Locker, Inc. (NYSE: FL) gained 15 percent to $53.35 after the company reported better-than-expected results for its first quarter. Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) surged 14.2 percent to $2.625. ArQule, Inc. (NASDAQ: ARQL) rose 13 percent to $5.12 after gaining 4.86 percent on Thursday. Quality Systems, Inc. (NASDAQ: QSII) gained 12.8 percent to $16.97 after the company posted better-than-expected FQ4 results. Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE: LOMA) shares rose 12 percent to $12.94. ArQule, Inc. (NASDAQ: ARQL) shares rose 12 percent to $5.07. Mirati Therapeutics, Inc. (NASDAQ: MRTX) climbed 11.4 percent to $43.50. Zai Lab Limited (NASDAQ: ZLAB) gained 11.3 percent to $24.7000. Zymeworks Inc. (NASDAQ: ZYME) rose 9.7 percent to $19.64. Park City Group, Inc. (NASDAQ: PCYG) climbed 9 percent to $7.90. Roku, Inc. (NASDAQ: ROKU) gained 7.9 percent to $38.82 after Citron reversed previously bearish position on the stock. Sears Holdings Corporation (NASDAQ: SHLD) shares jumped 7.3 percent to $3.55. Deckers Outdoor Corp (NYSE: DECK) rose 3.5 percent to $107.27 after reporting better-than-expected results for its fiscal fourth quarter.

  Check out these big penny stock gainers and losers

Top Safest Stocks To Watch For 2019

tags:NPI,TCRD,PRI,SMS, Currencies, commodities, different stock sectors, and bonds...   For the last few days, they've been all over the place.   Investors and traders are digesting the news. They're trying to figure out what "President Trump" means for the world. They're trying to figure out where their money is safest... and where they'll make the biggest profits.   Today, we'll look at a few areas of the market that are likely to do well under Trump...   I'll start with infrastructure. Trump plans to spend big to improve things like roads and bridges in the U.S. He has experience with construction. And he'll likely follow through on his promises here.   That bodes well for companies that produce building materials like stone, gravel, steel, and copper. Just look at the price action of companies like Martin Marietta Materials (MLM), Vulcan Materials (VMC), U.S. Steel (X), and Freeport-McMoRan (FCX) since the election. They've all shot higher.

Top Safest Stocks To Watch For 2019: Nuveen Premium Income Municipal Fund, Inc.(NPI)

Advisors' Opinion:

• [By Logan Wallace]

  Northland Power (TSE:NPI) is set to release its earnings data after the market closes on Wednesday, May 9th. Analysts expect Northland Power to post earnings of C$0.45 per share for the quarter.

Top Safest Stocks To Watch For 2019: THL Credit, Inc.(TCRD)

Advisors' Opinion:

• [By Max Byerly]

  Thl Credit (NASDAQ: TCRD) and Tian Ge Interactiv (OTCMKTS:TGRVF) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.

Top Safest Stocks To Watch For 2019: Primerica, Inc.(PRI)

Advisors' Opinion:

• [By Stephan Byrd]

  Wells Fargo & Company MN boosted its stake in Primerica (NYSE:PRI) by 2.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 838,510 shares of the financial services provider’s stock after purchasing an additional 19,142 shares during the quarter. Wells Fargo & Company MN’s holdings in Primerica were worth $81,000,000 as of its most recent SEC filing.

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
• [By Max Byerly]

  Great Lakes Advisors LLC bought a new position in shares of Primerica (NYSE:PRI) in the first quarter, according to the company in its most recent filing with the SEC. The firm bought 6,834 shares of the financial services provider’s stock, valued at approximately $660,000.

• [By Joseph Griffin]

  Primerica (NYSE:PRI) has been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-year target price among brokers that have issued a report on the stock in the last year is $103.00.

Top Safest Stocks To Watch For 2019: Sims Metal Management Limited(SMS)

Advisors' Opinion:

• [By Joseph Griffin]

  Speed Mining Service (CURRENCY:SMS) traded 4.2% higher against the dollar during the 24 hour period ending at 0:00 AM E.T. on May 20th. One Speed Mining Service token can now be purchased for $16.33 or 0.00192074 BTC on cryptocurrency exchanges including CoinExchange and HitBTC. Speed Mining Service has a market capitalization of $1.71 million and $413.00 worth of Speed Mining Service was traded on exchanges in the last 24 hours. Over the last seven days, Speed Mining Service has traded 4.2% lower against the dollar.

Buy PI Industries; target of Rs 954: Edelweiss

Edelweiss' research report on PI Industries

PI Industries (PI) reported a below estimate quarter (Revenue/PAT 14%/24% below estimate) driven by sharp miss in the CSM segment due to deferment of an order. However, domestic segment��s growth at 10% surpassed estimate on new product launches. Outlook for this segment has improved even further with more new product launches and management guiding for 18% growth in FY19��among the highest in the industry.

Outlook

Given the traction, we have also adjusted our revenue growth expectation for FY19 higher from 8% to 12%. However, factoring in the lower margin guidance, we cut FY19/20E EPS 8%/5%. We value PI at FY20E target P/E of 25.0x, leading to TP of INR954. We maintain ��BUY��.

For all recommendations report,�click here

Disclaimer:�The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More

AvalonBay Communities (AVB) Shares Sold by Aperio Group LLC

Aperio Group LLC lessened its position in shares of AvalonBay Communities (NYSE:AVB) by 13.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 54,141 shares of the real estate investment trust’s stock after selling 8,457 shares during the quarter. Aperio Group LLC’s holdings in AvalonBay Communities were worth $8,904,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in AVB. Capital Analysts LLC raised its stake in shares of AvalonBay Communities by 441.3% during the 4th quarter. Capital Analysts LLC now owns 2,230 shares of the real estate investment trust’s stock worth $116,000 after buying an additional 1,818 shares during the last quarter. Keeler Thomas Management LLC acquired a new position in shares of AvalonBay Communities during the 4th quarter worth $166,000. NuWave Investment Management LLC acquired a new position in shares of AvalonBay Communities during the 4th quarter worth $181,000. MUFG Americas Holdings Corp acquired a new position in shares of AvalonBay Communities during the 4th quarter worth $189,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of AvalonBay Communities during the 4th quarter worth $236,000. 93.10% of the stock is owned by institutional investors and hedge funds.

Get AvalonBay Communities alerts:

Several research firms have recently issued reports on AVB. Jefferies Group reaffirmed a “hold” rating and set a $166.00 price target on shares of AvalonBay Communities in a research note on Friday, April 13th. BMO Capital Markets set a $178.00 price target on AvalonBay Communities and gave the stock a “hold” rating in a research note on Monday, February 12th. SunTrust Banks reaffirmed a “buy” rating and set a $186.00 price target on shares of AvalonBay Communities in a research note on Friday, February 2nd. BTIG Research cut their price target on AvalonBay Communities to $189.00 and set a “buy” rating for the company in a research note on Thursday, March 15th. Finally, Zacks Investment Research raised AvalonBay Communities from a “sell” rating to a “hold” rating in a research note on Tuesday, April 17th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $188.94.

Shares of AvalonBay Communities opened at $159.25 on Wednesday, Marketbeat Ratings reports. AvalonBay Communities has a twelve month low of $152.65 and a twelve month high of $199.52. The stock has a market capitalization of $21.80 billion, a P/E ratio of 18.47, a PEG ratio of 2.41 and a beta of 0.35. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.75 and a quick ratio of 0.75.

AvalonBay Communities (NYSE:AVB) last announced its earnings results on Wednesday, April 25th. The real estate investment trust reported $1.03 earnings per share for the quarter, missing the consensus estimate of $2.19 by ($1.16). AvalonBay Communities had a net margin of 35.62% and a return on equity of 7.57%. The firm had revenue of $560.80 million during the quarter, compared to analyst estimates of $556.23 million. During the same period in the previous year, the firm posted $2.09 EPS. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. analysts expect that AvalonBay Communities will post 8.95 EPS for the current year.

AvalonBay Communities Profile

As of December 31, 2017, the Company owned or held a direct or indirect ownership interest in 288 apartment communities containing 84,158 apartment homes in 12 states and the District of Columbia, of which 21 communities were under development and nine communities were under redevelopment. The Company is an equity REIT in the business of developing, redeveloping, acquiring and managing apartment communities in leading metropolitan areas primarily in New England, the New York/New Jersey Metro area, the Mid-Atlantic, the Pacific Northwest, and the Northern and Southern California regions of the United States.

Want to see what other hedge funds are holding AVB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AvalonBay Communities (NYSE:AVB).

Vf Corp (VFC) Chairman, President & CEO Steven E Rendle Sold $5.9 million of Shares

Chairman, President & CEO of Vf Corp (NYSE:VFC) Steven E Rendle sold 74,180 shares of VFC on 05/18/2018 at an average price of $80.12 a share. The total sale was $5.9 million.

VF Corp owns a large portfolio of lifestyle brands including The North Face, Timberland, Vans, Lee, Wrangler, Nautica, and others. The company offers product into outdoor and action sports, jeanswear, imagewear, and sportswear. VF Corp has a market cap of $31.96 billion; its shares were traded at around $81.02 with a P/E ratio of 49.41 and P/S ratio of 2.64. The dividend yield of VF Corp stocks is 2.18%. VF Corp had annual average EBITDA growth of 8.50% over the past ten years. GuruFocus rated VF Corp the business predictability rank of 2-star.

CEO Recent Trades:

Chairman, President & CEO Steven E Rendle sold 74,180 shares of VFC stock on 05/18/2018 at the average price of $80.12. The price of the stock has increased by 1.12% since.

CFO Recent Trades:

VP & CFO Scott A. Roe sold 20,096 shares of VFC stock on 05/18/2018 at the average price of $79.78. The price of the stock has increased by 1.55% since.

Directors and Officers Recent Trades:

Director Juliana L Chugg sold 25,540 shares of VFC stock on 05/16/2018 at the average price of $79. The price of the stock has increased by 2.56% since.VP & Group Pres. - APAC Kevin Bailey sold 15,000 shares of VFC stock on 05/14/2018 at the average price of $77.42. The price of the stock has increased by 4.65% since.

For the complete insider trading history of VFC, click here

.

Wells Fargo Cuts 22 Jobs in Currency Trading

Wells Fargo & Co.’s foreign-exchange business cut 22 salespeople, according to a person briefed on the matter, the latest casualties of a slump in market activity.

Affected employees worked in locations including St. Louis and Atlanta, where the bank is consolidating operations elsewhere, the person said. Some staff are being moved to other offices, while others leave the company, the person said.

“Wells Fargo is fully committed to our FX business,” Jessica Ong, a spokeswoman for the San Francisco-based bank, said Monday in an emailed statement. “We continually evaluate our resources and staffing levels to ensure we are aligned to meet the needs of our customers as part of normal course of business.” She confirmed that operations in St. Louis and Atlanta are being moved.

The $5.1 trillion-a-day currency market has been plagued by low volatility, even amid heightened trade and geopolitical tensions over the past year, making it harder to eke out profits on swings. In March, the lender said it’s responding to queries from government agencies into its foreign-exchange business. Several employees left the unit last year over a transaction for a client, the company said at the time.

Read more on Wells Fargo: CEO Sloan says bank to boost auto lending

LISTEN TO ARTICLE 1:11 Share Share on Facebook Post to Twitter Send as an Email Print

American Century Companies Inc. Sells 605,777 Shares of eBay (EBAY)

American Century Companies Inc. trimmed its holdings in shares of eBay (NASDAQ:EBAY) by 64.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 327,429 shares of the e-commerce company’s stock after selling 605,777 shares during the quarter. American Century Companies Inc.’s holdings in eBay were worth $13,176,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in EBAY. OppenheimerFunds Inc. increased its position in shares of eBay by 29,058.6% during the fourth quarter. OppenheimerFunds Inc. now owns 9,881,553 shares of the e-commerce company’s stock worth $372,929,000 after acquiring an additional 9,847,664 shares during the last quarter. Swedbank purchased a new stake in shares of eBay during the fourth quarter worth about $123,834,000. Arrowstreet Capital Limited Partnership increased its position in shares of eBay by 141.6% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,838,533 shares of the e-commerce company’s stock worth $107,126,000 after acquiring an additional 1,663,600 shares during the last quarter. Lazard Asset Management LLC increased its position in shares of eBay by 7.6% during the fourth quarter. Lazard Asset Management LLC now owns 22,610,368 shares of the e-commerce company’s stock worth $853,313,000 after acquiring an additional 1,595,771 shares during the last quarter. Finally, Amundi Pioneer Asset Management Inc. increased its position in shares of eBay by 26.6% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 6,694,129 shares of the e-commerce company’s stock worth $252,637,000 after acquiring an additional 1,407,062 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Get eBay alerts:

eBay opened at $38.32 on Friday, MarketBeat Ratings reports. The company has a market cap of $38.17 billion, a PE ratio of 23.51, a P/E/G ratio of 1.86 and a beta of 1.26. eBay has a 52 week low of $33.60 and a 52 week high of $46.99. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.63 and a quick ratio of 2.63.

eBay (NASDAQ:EBAY) last posted its earnings results on Wednesday, April 25th. The e-commerce company reported $0.53 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.53. The company had revenue of $2.58 billion during the quarter, compared to analyst estimates of $2.59 billion. eBay had a positive return on equity of 18.06% and a negative net margin of 16.56%. The business’s revenue was up 12.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 earnings per share. equities research analysts anticipate that eBay will post 1.84 EPS for the current year.

eBay declared that its Board of Directors has initiated a stock buyback program on Wednesday, January 31st that allows the company to buyback $6.00 billion in shares. This buyback authorization allows the e-commerce company to repurchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

A number of analysts have recently issued reports on the company. Bank of America lifted their target price on eBay from $44.00 to $52.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. UBS reaffirmed a “buy” rating and set a $48.00 target price (up from $44.00) on shares of eBay in a research report on Thursday, February 1st. Canaccord Genuity reaffirmed a “hold” rating and set a $43.00 target price on shares of eBay in a research report on Thursday, February 1st. Stifel Nicolaus lifted their target price on eBay from $37.00 to $41.00 and gave the stock a “hold” rating in a research report on Thursday, February 1st. Finally, Goldman Sachs set a $49.00 target price on eBay and gave the stock a “buy” rating in a research report on Thursday, February 1st. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating, twenty-two have issued a buy rating and one has assigned a strong buy rating to the company. eBay presently has an average rating of “Buy” and an average target price of $46.13.

In other news, CFO Scott F. Schenkel sold 131,332 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $43.25, for a total transaction of $5,680,109.00. Following the completion of the transaction, the chief financial officer now directly owns 91,757 shares in the company, valued at $3,968,490.25. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Jae Hyun Lee sold 14,565 shares of the business’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $43.52, for a total value of $633,868.80. Following the transaction, the senior vice president now owns 99,110 shares of the company’s stock, valued at $4,313,267.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 407,836 shares of company stock valued at $16,930,138. Insiders own 6.78% of the company’s stock.

eBay Company Profile

eBay Inc operates commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer their inventory for sale; and buyers to find and purchase it virtually. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com, and the StubHub mobile apps and online ticket platform that connect fans with their favorite sporting events, shows, and artists, as well as enables them to buy and sell tickets.

Want to see what other hedge funds are holding EBAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for eBay (NASDAQ:EBAY).

Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Vertex Pharmaceuticals (VRTX) Share Pr

News coverage about Vertex Pharmaceuticals (NASDAQ:VRTX) has been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Vertex Pharmaceuticals earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave headlines about the pharmaceutical company an impact score of 45.6966268074944 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the media stories that may have effected Accern’s rankings:

Get Vertex Pharmaceuticals alerts: Global Respiratory Drugs (Pharmacuticals / Healthcare) Market 2018-2024 – ResearchAndMarkets.com (oaoa.com) What Irrational Exuberance Behind the Bloomin’ Brands, Inc. (BLMN) and Vertex Pharmaceuticals Incorporated (VRTX)? (nmsunews.com) $674.90 Million in Sales Expected for Vertex Pharmaceuticals (VRTX) This Quarter (americanbankingnews.com) Vertex Pharmaceuticals (VRTX) EVP Sells $21,497.64 in Stock (americanbankingnews.com) Vertex Pharmaceuticals (VRTX) COO Sells $33,804.26 in Stock (americanbankingnews.com)

A number of brokerages have issued reports on VRTX. Barclays increased their target price on shares of Vertex Pharmaceuticals from $180.00 to $200.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. TheStreet upgraded shares of Vertex Pharmaceuticals from a “c+” rating to a “b-” rating in a research report on Friday, March 2nd. HC Wainwright restated a “hold” rating and set a $103.00 target price on shares of Vertex Pharmaceuticals in a research report on Thursday, February 1st. Zacks Investment Research lowered shares of Vertex Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a research report on Sunday, January 21st. Finally, BidaskClub lowered shares of Vertex Pharmaceuticals from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 9th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and twenty-six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $184.54.

Shares of Vertex Pharmaceuticals traded up $0.90, reaching $157.24, on Friday, Marketbeat Ratings reports. 998,525 shares of the stock were exchanged, compared to its average volume of 1,698,350. Vertex Pharmaceuticals has a one year low of $115.10 and a one year high of $178.25. The company has a current ratio of 3.68, a quick ratio of 3.53 and a debt-to-equity ratio of 0.01. The company has a market cap of $39.79 billion, a PE ratio of 196.55, a price-to-earnings-growth ratio of 1.91 and a beta of 1.44.

Vertex Pharmaceuticals (NASDAQ:VRTX) last issued its quarterly earnings data on Thursday, April 26th. The pharmaceutical company reported $0.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.13. The business had revenue of $641.00 million during the quarter, compared to the consensus estimate of $626.05 million. Vertex Pharmaceuticals had a net margin of 9.36% and a return on equity of 15.28%. The firm’s revenue was down 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.99 EPS. research analysts forecast that Vertex Pharmaceuticals will post 1.95 earnings per share for the current year.

Vertex Pharmaceuticals declared that its Board of Directors has approved a stock buyback plan on Wednesday, January 31st that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the pharmaceutical company to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.

In related news, COO Ian F. Smith sold 85,093 shares of the stock in a transaction that occurred on Thursday, April 26th. The shares were sold at an average price of $158.32, for a total value of $13,471,923.76. Following the completion of the transaction, the chief operating officer now owns 68,745 shares of the company’s stock, valued at approximately $10,883,708.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Michael Parini sold 2,330 shares of the stock in a transaction that occurred on Thursday, May 3rd. The shares were sold at an average price of $149.50, for a total transaction of $348,335.00. Following the completion of the transaction, the executive vice president now directly owns 41,939 shares of the company’s stock, valued at approximately $6,269,880.50. The disclosure for this sale can be found here. In the last three months, insiders sold 172,907 shares of company stock valued at $27,820,874. 1.80% of the stock is owned by insiders.

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI (lumacaftor in combination with ivacaftor) to treat patients with CF 12 years of age and older who are homozygous for the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; KALYDECO (ivacaftor) for the treatment of patients with CF who have specific mutations in their CFTR gene, including the G551D mutation; and SYMDEKO (tezacaftor in combination with ivacaftor) to treat patients with CF 12 years of age and older who are F508del homozygous or who have 1 mutation that is responsive to tezacaftor/ivacaftor.